CLINICAL STUDY: ACUTE CORONARY SYNDROMES
Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
Nazneem N. Wahab, MD*,
Elizabeth A. Cowden, MD ,
Neil J. Pearce, MD*,
Martin J. Gardner, MD*,
Heather Merry, MSc*,
Jafna L. Cox, MD* ,* ICONS Investigators
* Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada
Division of Endocrinology, Dalhousie University, Halifax, Nova Scotia, Canada
Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
Manuscript received April 18, 2002;
revised manuscript received June 26, 2002,
accepted July 24, 2002.
* Reprint requests and correspondence: Dr. Jafna L. Cox, Director of Health Services and Outcomes Research, Division of Cardiology, Queen Elizabeth II Health Sciences Centre, New Halifax Infirmary Site, Room 2147, 1796 Summer Street, Halifax, Nova Scotia B3H 3A7, Canada.
coxjl{at}is.dal.ca
OBJECTIVES: This study was designed to assess the prognostic significance of hyperglycemia in acute myocardial infarction (AMI) in the thrombolytic era using contemporary criteria for hyperglycemia.
BACKGROUND: Most studies that have examined this issue were performed before the widespread use of disease-modifying therapies and varied in their definition of hyperglycemia, assessment of risk factors, and reported outcomes.
METHODS: There were 1,664 consecutively hospitalized patients with AMI between October 1997 and October 1998 from a disease-specific, population-based registry. Patients were stratified according to history of diabetes mellitus and, further, according to whether they had a blood glucose >198 mg/dl (11 mmol/l). The influences of cardiac risk factors, medications, and interventions were analyzed, and multivariate logistic regression was used to determine the influence of blood glucose on mortality.
RESULTS: In patients without a history of diabetes, glucose levels were  198 mg/dl in 1,078 patients (Group 1) and >198 mg/dl in 135 (Group 2). Of those with diabetes, glucose levels were 198 mg/dl in 169 patients (Group 3) and >198 mg/dl in 282 (Group 4). Compared with Group 1 patients, the odds ratios (95% confidence interval) for in-hospital mortality among those in Groups 2, 3, and 4 were 2.44 (1.42 to 4.20; p = 0.001), 1.87 (1.05 to 3.34; p = 0.035), and 1.91 (1.16 to 3.14; p = 0.011), respectively. These groups also had greater 12-month mortality.
CONCLUSIONS: Hyperglycemia in AMI is associated with poor outcome even among patients without known diabetes. This finding underlines the need for aggressive glucose management in this setting and may support a more vigorous screening strategy for early recognition of diabetes.
|
Abbreviations and Acronyms
| | AMI | | acute myocardial infarction | | CAD | | coronary artery disease | | CHF | | congestive heart failure | | ICONS | | Improving Cardiovascular Outcomes in Nova Scotia |
|
This article has been cited by other articles:
|
|
|
|
 
P. Knapik, P. Nadziakiewicz, E. Urbanska, W. Saucha, M. Herdynska, and M. Zembala
Cardiopulmonary Bypass Increases Postoperative Glycemia and Insulin Consumption After Coronary Surgery.
Ann. Thorac. Surg.,
June 1, 2009;
87(6):
1859 - 1865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Anantharaman, M Heatley, and C F M Weston
Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
Heart,
May 1, 2009;
95(9):
697 - 703.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod, S. E. Inzucchi, A. Goyal, H. M. Krumholz, F. A. Masoudi, L. Xiao, and J. A. Spertus
Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction
JAMA,
April 15, 2009;
301(15):
1556 - 1564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod, S. E. Inzucchi, J. A. Spertus, Y. Wang, F. A. Masoudi, E. P. Havranek, and H. M. Krumholz
Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart Failure
Circulation,
April 14, 2009;
119(14):
1899 - 1907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, F. A. Masoudi, A. Goyal, L. Xiao, P. G. Jones, S. Fiske, and J. A. Spertus
Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction
Arch Intern Med,
March 9, 2009;
169(5):
438 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.
J. Thorac. Cardiovasc. Surg.,
March 1, 2009;
137(3):
723 - 729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Sinnaeve, P. G. Steg, K. A. A. Fox, F. Van de Werf, G. Montalescot, C. B. Granger, E. Knobel, F. A. Anderson, O. H. Dabbous, A. Avezum, et al.
Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non-ST-Segment Elevation Acute Coronary Syndromes: The Global Registry of Acute Coronary Events
Arch Intern Med,
February 23, 2009;
169(4):
402 - 409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Timmers, J. P.S. Henriques, D. P.V. de Kleijn, J. H. DeVries, H. Kemperman, P. Steendijk, C. W.J. Verlaan, M. Kerver, J. J. Piek, P. A. Doevendans, et al.
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
J. Am. Coll. Cardiol.,
February 10, 2009;
53(6):
501 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ceriello, S. W. Zarich, and R. Testa
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5 Suppl):
S9 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty
Insulin as an anti-inflammatory and antiatherogenic modulator.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5 Suppl):
S14 - S20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Umpierrez, T. Hor, D. Smiley, A. Temponi, D. Umpierrez, M. Ceron, C. Munoz, C. Newton, L. Peng, and D. Baldwin
Comparison of Inpatient Insulin Regimens with Detemir plus Aspart Versus Neutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
February 1, 2009;
94(2):
564 - 569.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod
Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction
Diabetes and Vascular Disease Research,
November 1, 2008;
5(4):
269 - 275.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Goyal, K. Nerenberg, H. C Gerstein, G. Umpierrez, and P. W. Wilson
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points
Diabetes and Vascular Disease Research,
November 1, 2008;
5(4):
276 - 284.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. C. Lansang and G. E. Umpierrez
Management of Inpatient Hyperglycemia in Noncritically Ill Patients
Diabetes Spectr,
October 1, 2008;
21(4):
248 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz
Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
Diabetes Care,
August 1, 2008;
31(8):
1590 - 1595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Kloner and R. W. Nesto
Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection
Circulation,
May 13, 2008;
117(19):
2523 - 2533.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone, and P. Raskin
Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation,
March 25, 2008;
117(12):
1610 - 1619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Nesto and R. M. Lago
Glucose: A Biomarker in Acute Myocardial Infarction Ready for Prime Time?
Circulation,
February 26, 2008;
117(8):
990 - 992.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, L. Xiao, P. G. Jones, S. Fiske, F. A. Masoudi, S. P. Marso, and J. A. Spertus
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk
Circulation,
February 26, 2008;
117(8):
1018 - 1027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Mudespacher, D. Radovanovic, E. Camenzind, M. Essig, O. Bertel, P. Erne, F. R. Eberli, and F. Gutzwiller
Admission glycaemia and outcome in patients with acute coronary syndrome
Diabetes and Vascular Disease Research,
December 1, 2007;
4(4):
346 - 352.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. W. Zarich and R. W. Nesto
Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction
Circulation,
May 8, 2007;
115(18):
e436 - e439.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ishihara, I. Inoue, T. Kawagoe, Y. Shimatani, S. Kurisu, T. Hata, Y. Nakama, Y. Kijima, and E. Kagawa
Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?
Eur. Heart J.,
October 2, 2006;
27(20):
2413 - 2419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. A. Smit and J. A. Romijn
Acute insulin resistance in myocardial ischemia: causes and consequences.
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2006;
10(3):
215 - 219.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Barsheshet, M. Garty, E. Grossman, A. Sandach, B. S. Lewis, S. Gottlieb, A. Shotan, S. Behar, A. Caspi, R. Schwartz, et al.
Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.
Arch Intern Med,
August 14, 2006;
166(15):
1613 - 1619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Goyal, K. W. Mahaffey, J. Garg, J. C. Nicolau, J. S. Hochman, W. D. Weaver, P. Theroux, G. B.F. Oliveira, T. G. Todaro, C. F. Mojcik, et al.
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Eur. Heart J.,
June 1, 2006;
27(11):
1289 - 1297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.R. Timmer, J.P. Ottervanger, H.J.G. Bilo, J.H.E. Dambrink, K. Miedema, J.C.A. Hoorntje, and F. Zijlstra
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes
QJM,
April 1, 2006;
99(4):
237 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Ellger, Y. Debaveye, I. Vanhorebeek, L. Langouche, A. Giulietti, E. Van Etten, P. Herijgers, C. Mathieu, and G. Van den Berghe
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Diabetes,
April 1, 2006;
55(4):
1096 - 1105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Collet and G. Montalescot
The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes
Diabetes and Vascular Disease Research,
October 1, 2005;
2(3):
136 - 143.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
Eur. Heart J.,
July 1, 2005;
26(13):
1255 - 1261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kosiborod, S. S. Rathore, S. E. Inzucchi, F. A. Masoudi, Y. Wang, E. P. Havranek, and H. M. Krumholz
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes
Circulation,
June 14, 2005;
111(23):
3078 - 3086.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Zeller, P. G. Steg, J. Ravisy, Y. Laurent, L. Janin-Manificat, I. L'Huillier, J.-C. Beer, A. Oudot, G. Rioufol, H. Makki, et al.
Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
Arch Intern Med,
May 23, 2005;
165(10):
1192 - 1198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Timmer, J. P. Ottervanger, M.-J. de Boer, J.-H. E. Dambrink, J. C.A. Hoorntje, A.T. M. Gosselink, H. Suryapranata, F. Zijlstra, A. W.J. van't Hof, and Zwolle Myocardial Infarction Study Group
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
J. Am. Coll. Cardiol.,
April 5, 2005;
45(7):
999 - 1002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. A. McAlister, S. R. Majumdar, S. Blitz, B. H. Rowe, J. Romney, and T. J. Marrie
The Relation Between Hyperglycemia and Outcomes in 2,471 Patients Admitted to the Hospital With Community-Acquired Pneumonia
Diabetes Care,
April 1, 2005;
28(4):
810 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M Conner, K. R Flesner-Gurley, and J. C Barner
Hyperglycemia in the Hospital Setting: The Case for Improved Control Among Non-Diabetics
Ann. Pharmacother.,
March 1, 2005;
39(3):
492 - 501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ceriello
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction
Eur. Heart J.,
February 2, 2005;
26(4):
328 - 331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
The CREATE-ECLA Trial Group Investigators*
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATE-ECLA Randomized Controlled Trial
JAMA,
January 26, 2005;
293(4):
437 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ceriello
Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction
Diabetes Care,
December 1, 2004;
27(12):
3017 - 3018.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Ohrvik, and L. Ryden
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction
Eur. Heart J.,
November 2, 2004;
25(22):
1990 - 1997.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al.
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Circulation,
September 21, 2004;
110(12):
1572 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Cely, P. Arora, A. A. Quartin, D. H. Kett, and R. M. H. Schein
Relationship of Baseline Glucose Homeostasis to Hyperglycemia During Medical Critical Illness
Chest,
September 1, 2004;
126(3):
879 - 887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. T. Bloomgarden
Inpatient Diabetes Control: Rationale
Diabetes Care,
August 1, 2004;
27(8):
2074 - 2080.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Krinsley
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Mayo Clin. Proc.,
August 1, 2004;
79(8):
992 - 1000.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. L. Lazar, S. R. Chipkin, C. A. Fitzgerald, Y. Bao, H. Cabral, and C. S. Apstein
Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events
Circulation,
March 30, 2004;
109(12):
1497 - 1502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Goldberg, M. D. Siegel, R. S. Sherwin, J. I. Halickman, M. Lee, V. A. Bailey, S. L. Lee, J. D. Dziura, and S. E. Inzucchi
Implementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care Unit
Diabetes Care,
February 1, 2004;
27(2):
461 - 467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tenerz, A. Norhammar, A. Silveira, A. Hamsten, G. Nilsson, L. Ryden, and K. Malmberg
Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes
Diabetes Care,
October 1, 2003;
26(10):
2770 - 2776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Brady and A. Jovanovic
The sulfonylurea controversy: Much ado about nothing or cause for concern?
J. Am. Coll. Cardiol.,
September 17, 2003;
42(6):
1022 - 1025.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
June 1, 2003;
88(6):
2422 - 2429.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. A. McAlister, J. Man, L. Bistritz, H. Amad, and P. Tandon
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes
Diabetes Care,
May 1, 2003;
26(5):
1518 - 1524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
